Incidence of Secondary Malignancy after Treatment with Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor T-Cell Therapies

被引：0
|
作者：
Jones, Can [1 ]
Fares, Amneh A. [2 ]
Martinez, Diana [2 ]
Logue, Jennifer M. [3 ]
Rondon, Carlos Silva [3 ]
Madueno, Fernando Vargas [4 ,5 ]
Nguyen, Nina [3 ]
Fernandez, Hugo Francisco [6 ]
Chavez, Julio C. [7 ,8 ]
Sandoval-Sus, Jose [9 ]
机构：
[1] Mem Healthcare Syst, Dept Hematol & Oncol, Miramar, FL USA
[2] Mem Healthcare Syst, Dept Pharm, Pembroke Pines, FL USA
[3] Mem Hlth Syst, Moffitt Canc Ctr, Pembroke Pines, FL USA
[4] Mem Healthcare Syst, Moffitt Canc Ctr, Pembroke Pines, FL USA
[5] Mem Healthcare Syst, Dept Malignant Hematol & Cellular Therapy, Moffitt Canc Ctr, Pembroke Pines, FL USA
[6] Moffitt Malignant Hematol & Cellular Therapy, Pembroke Pines, FL USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[9] Mem Healthcare Syst, Mem Canc Inst, Moffitt Malignant Hematol & Cellular Therapy, Pembroke Pines, FL USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206293
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7241 / 7242
页数：2
相关论文
共 50 条
  • [1] T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy
    Martin, Lisa J.
    Whitmore, James B.
    Shen, Rhine R.
    Neumann, Frank
    BLOOD ADVANCES, 2024, 8 (15) : 4144 - 4148
  • [2] Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia
    Liu, Y.
    Chen, X.
    Han, W.
    Zhang, Y.
    DRUGS OF TODAY, 2017, 53 (11) : 597 - 608
  • [3] CARDIAC EVENTS AFTER ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T-CELL (IDECABTAGENE VICLEUCEL) FOR MULTIPLE MYELOMA
    Lee, Dae Hyun
    Chandrasekhar, Sanjay Amrith
    Jain, Michael
    Hansen, Doris
    Freeman, Ciara
    Alsina, Melissa
    Baz, Rachid
    Puglianini, Omar Castaneda
    Liu, Hien
    Blue, Brandon
    Davila, Marco L.
    Faramand, Rawan
    Kumar, Abhishek
    Shah, Bijal
    Lazaryan, Aleksandr
    Khimani, Farhad
    Nishihori, Taiga
    Bachmeier, Christina
    Locke, Frederick
    Oliveira, Guilherme Henrique
    Alomar, Mohammed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1933 - 1933
  • [4] Myelodysplastic Syndrome After Anti-CD19 Chimeric Antigen Receptor T-cell Therapy: A Case Series
    Dhaliwal, Armaan
    Ravi, Soumiya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [5] Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy
    Mian, Agrima
    Andrapalliyal, Nirmal
    Weathers, Allison L.
    Pohlman, Brad
    Hill, Brian T.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 584 - 588
  • [6] Efficacy and Safety of Anti-CDI9 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma
    Paruzzo, Luca
    Bouvier, Riemke
    Ghilardi, Guido
    Fardella, Eugenio
    Fulmer, Bria
    Cohen, Ivan J.
    Chong, Elise A.
    Svoboda, Jakub
    Nasta, Sunita D.
    Landsburg, Daniel J.
    Patel, Vrutti
    Ziyu, Li
    Pajarillo, Raymone
    Waxman, Adam
    Cohen, Adam D.
    Vogl, Dan T.
    Barta, Stefan K.
    Porazzi, Patrizia
    Fraietta, Joseph A.
    Bhoj, Vijay
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    Schuster, Stephen J.
    Carter, Jordan S.
    Apostolidis, Sokratis A.
    Susanibar-Adaniya, Sandra
    Ruella, Marco
    BLOOD, 2024, 144 : 7243 - 7244
  • [7] Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties
    Haidar, Ghady
    Garner, Will
    Hill, Joshua A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2020, 33 (06) : 449 - 457
  • [8] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
  • [9] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
  • [10] HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma
    Lebel, Eyal
    Asherie, Nathalie
    Kfir-Erenfeld, Shlomit
    Grisariu, Sigal
    Avni, Batia
    Elias, Shlomo
    Assayag, Miri
    Dubnikov-Sharon, Tali
    Zimran, Eran
    Shaulov, Adir
    Pick, Marjorie
    Cohen, Cyrille
    Stepensky, Polina
    Gatt, Moshe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S22 - S22
12345